Peptide-based cancer vaccines

被引：68
|
作者：
Melief, CJM [1 ]
Offringa, R [1 ]
Toes, REM [1 ]
Kast, WM [1 ]
机构：
[1] LOYOLA UNIV, CARDINAL BERNADIN CANC CTR, CANC IMMUNOL PROGRAM, MAYWOOD, IL 60153 USA
来源：
CURRENT OPINION IN IMMUNOLOGY | 1996年 / 8卷 / 05期
关键词：
D O I：
10.1016/S0952-7915(96)80081-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The application of molecularly defined vaccines composed of a limited number of tumor-specific T cell epitopes has resulted in protective antitumor T cell immunity in several mouse tumor models. The first encouraging results with such vaccines have been obtained in human beings. The development of the next generation of rationally designed vaccines that are both effective and safe for application in a clinical setting requires comparison of different modes of delivery of tumor-associated T cell epitopes in multiple epitope constructs.
引用
收藏
页码：651 / 657
页数：7
相关论文
共 50 条
  • [21] Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
    Stephens, Alexander J.
    Burgess-Brown, Nicola A.
    Jiang, Shisong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [22] Peptide-Based Immunotherapeutics and Vaccines 2015
    Reche, Pedro
    Flower, Darren R.
    Fridkis-Hareli, Masha
    Hoshino, Yoshihiko
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [23] SYNTHETIC PEPTIDE VACCINES - DESIGN AND SYNTHESIS OF UNAMBIGUOUS PEPTIDE-BASED VACCINES
    TAM, JP
    BIOCHEMISTRY, 1990, 29 (08) : 2204 - 2204
  • [24] SYNTHETIC PEPTIDE VACCINES - DESIGN AND SYNTHESIS OF UNAMBIGUOUS PEPTIDE-BASED VACCINES
    TAM, JP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 133 - BIOL
  • [25] Peptide-Based Immunotherapeutics and Vaccines 2017
    Reche, Pedro
    Flower, Darren R.
    Fridkis-Hareli, Masha
    Hoshino, Yoshihiko
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [26] Synthetic Peptide-Based Cancer Vaccines: Lessons Learned and Hurdles to Overcome
    Voskens, Caroline J.
    Strome, Scott E.
    Sewell, Duane A.
    CURRENT MOLECULAR MEDICINE, 2009, 9 (06) : 683 - 693
  • [27] The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
    Hussein Sultan
    Takumi Kumai
    Toshihiro Nagato
    Juan Wu
    Andres M. Salazar
    Esteban Celis
    Cancer Immunology, Immunotherapy, 2019, 68 : 455 - 466
  • [28] Potential association factors for developing effective peptide-based cancer vaccines
    Jiang, Chongming
    Li, Jianrong
    Zhang, Wei
    Zhuang, Zhenkun
    Liu, Geng
    Hong, Wei
    Li, Bo
    Zhang, Xiuqing
    Chao, Cheng-Chi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
    Morgan Grau
    Paul R. Walker
    Madiha Derouazi
    Cellular and Molecular Life Sciences, 2018, 75 : 2887 - 2896
  • [30] The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
    Sultan, Hussein
    Kumai, Takumi
    Nagato, Toshihiro
    Wu, Juan
    Salazar, Andres M.
    Celis, Esteban
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (03) : 455 - 466
12345